This Tf‐NLC/pEGFP showed higher transfection efficiency as observed in in vitro and in vivo studies than the non‐targeted NLC/pEGFP–suggesting this NLC system could be a promising vehicle for gene therapy in lung cancer.[154]. The gene discussed is TF; the disease is lung cancer.